Logo

TriPath Shareholders OK BD's $350M Acquisition Bid

Dec 19, 2006
NEW YORK (GenomeWeb News) — TriPath Imaging today said that its shareholders have approved Becton Dickinson’s $350-million bid to acquire the company.
 
The company said it expects the deal to close by tomorrow.
 
In September, BD said it would acquire 93.5 percent of TriPath’s shares for $350 million. TriPath said today that BD has agreed to pay $9.25 a share for the firm’s common stock, which is where the stock was trading this afternoon.

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.